BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32725458)

  • 1. Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target.
    Lapa B; Gonçalves AC; Jorge J; Alves R; Pires AS; Abrantes AM; Coucelo M; Abrunhosa A; Botelho MF; Nascimento-Costa JM; Sarmento-Ribeiro AB
    Med Oncol; 2020 Jul; 37(8):72. PubMed ID: 32725458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy metabolism of leukemia cells: glycolysis versus oxidative phosphorylation.
    Suganuma K; Miwa H; Imai N; Shikami M; Gotou M; Goto M; Mizuno S; Takahashi M; Yamamoto H; Hiramatsu A; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Leuk Lymphoma; 2010 Nov; 51(11):2112-9. PubMed ID: 20860495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIGAR cooperated with glycolysis to inhibit the apoptosis of leukemia cells and associated with poor prognosis in patients with cytogenetically normal acute myeloid leukemia.
    Qian S; Li J; Hong M; Zhu Y; Zhao H; Xie Y; Huang J; Lian Y; Li Y; Wang S; Mao J; Chen Y
    J Hematol Oncol; 2016 Nov; 9(1):128. PubMed ID: 27884166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells.
    Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L
    Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia cells demonstrate a different metabolic perturbation provoked by 2-deoxyglucose.
    Miwa H; Shikami M; Goto M; Mizuno S; Takahashi M; Tsunekawa-Imai N; Ishikawa T; Mizutani M; Horio T; Gotou M; Yamamoto H; Wakabayashi M; Watarai M; Hanamura I; Imamura A; Mihara H; Nitta M
    Oncol Rep; 2013 May; 29(5):2053-7. PubMed ID: 23440281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine.
    Yucel B; Sonmez M
    Hematology; 2018 Jul; 23(6):330-336. PubMed ID: 29139328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antileukemic Activity of 2-Deoxy-d-Glucose through Inhibition of N-Linked Glycosylation in Acute Myeloid Leukemia with FLT3-ITD or c-KIT Mutations.
    Larrue C; Saland E; Vergez F; Serhan N; Delabesse E; Mansat-De Mas V; Hospital MA; Tamburini J; Manenti S; Sarry JE; Récher C
    Mol Cancer Ther; 2015 Oct; 14(10):2364-73. PubMed ID: 26206337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mTOR pathway sensitizes acute myeloid leukemia cells to aurora inhibitors by suppression of glycolytic metabolism.
    Liu LL; Long ZJ; Wang LX; Zheng FM; Fang ZG; Yan M; Xu DF; Chen JJ; Wang SW; Lin DJ; Liu Q
    Mol Cancer Res; 2013 Nov; 11(11):1326-36. PubMed ID: 24008673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.
    Liu T; Kishton RJ; Macintyre AN; Gerriets VA; Xiang H; Liu X; Abel ED; Rizzieri D; Locasale JW; Rathmell JC
    Cell Death Dis; 2014 Oct; 5(10):e1470. PubMed ID: 25321477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomycin-induced bioenergetic adaptation in cancer cells with heterogeneous bioenergetic organization.
    Hao W; Chang CP; Tsao CC; Xu J
    J Biol Chem; 2010 Apr; 285(17):12647-54. PubMed ID: 20110356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytotoxicity of the glycolytic inhibitor 2-deoxy-D-glucose in isogenic cell lines varying in their p53 status.
    Vibhuti A; Muralidhar K; Dwarakanath BS
    J Cancer Res Ther; 2013; 9(4):686-92. PubMed ID: 24518718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioenergetic properties of human sarcoma cells help define sensitivity to metabolic inhibitors.
    Issaq SH; Teicher BA; Monks A
    Cell Cycle; 2014; 13(7):1152-61. PubMed ID: 24553119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential sensitivities of glioblastoma cell lines towards metabolic and signaling pathway inhibitions.
    Kennedy CR; Tilkens SB; Guan H; Garner JA; Or PM; Chan AM
    Cancer Lett; 2013 Aug; 336(2):299-306. PubMed ID: 23523615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposing effects of 2-deoxy-d-glucose on interictal- and ictal-like activity when K
    Nedergaard S; Andreasen M
    J Neurophysiol; 2018 May; 119(5):1912-1923. PubMed ID: 29412775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AZD-7648, a DNA-PK Inhibitor, Induces DNA Damage, Apoptosis, and Cell Cycle Arrest in Chronic and Acute Myeloid Leukemia Cells.
    Lapa BS; Costa MI; Figueiredo D; Jorge J; Alves R; Monteiro AR; Serambeque B; Laranjo M; Botelho MF; Carreira IM; Sarmento-Ribeiro AB; Gonçalves AC
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboxyamidotriazole inhibits oxidative phosphorylation in cancer cells and exerts synergistic anti-cancer effect with glycolysis inhibition.
    Ju R; Guo L; Li J; Zhu L; Yu X; Chen C; Chen W; Ye C; Zhang D
    Cancer Lett; 2016 Jan; 370(2):232-41. PubMed ID: 26522259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Cellular Metabolism in Acute Myeloid Leukemia and The Role of Patient Heterogeneity.
    Grønningsæter IS; Reikvam H; Aasebø E; Bartaula-Brevik S; Tvedt TH; Bruserud Ø; Hatfield KJ
    Cells; 2020 May; 9(5):. PubMed ID: 32392896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic rewiring in drug resistant cells exhibit higher OXPHOS and fatty acids as preferred major source to cellular energetics.
    Salunkhe S; Mishra SV; Ghorai A; Hole A; Chandrani P; Dutt A; Chilakapati M; Dutt S
    Biochim Biophys Acta Bioenerg; 2020 Dec; 1861(12):148300. PubMed ID: 32858000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic alterations and drug sensitivity of tyrosine kinase inhibitor resistant leukemia cells with a FLT3/ITD mutation.
    Huang A; Ju HQ; Liu K; Zhan G; Liu D; Wen S; Garcia-Manero G; Huang P; Hu Y
    Cancer Lett; 2016 Jul; 377(2):149-57. PubMed ID: 27132990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN/AKT signaling mediates chemoresistance in refractory acute myeloid leukemia through enhanced glycolysis.
    Ryu MJ; Han J; Kim SJ; Lee MJ; Ju X; Lee YL; Son JH; Cui J; Jang Y; Chung W; Song IC; Kweon GR; Heo JY
    Oncol Rep; 2019 Nov; 42(5):2149-2158. PubMed ID: 31545464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.